A beneficial effect on mood in partial epilepsy patients treated with gabapentin

Epilepsia

Volumn 40, Issue 8, 1999, Pages 1129-1134

  Harden, Cynthia L ^a   Lazar, Lorraine M ^a   Pick, Lawrence H ^a   Nikolov, Blagovest ^a   Goldstein, Martin A ^a   Carson, Deborah ^a   Ravdin, Lisa D ^a   Kocsis, James H ^a   Labar, Douglas R ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Depression; Dysthymia; Epilepsy; Gabapentin; Mood

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLONAZEPAM; GABAPENTIN; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; TOPIRAMATE; VALPROIC ACID;

ADULT; ANTICONVULSANT THERAPY; ANXIETY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE CONTROL; DYSTHYMIA; FEMALE; FOCAL EPILEPSY; FOLLOW UP; HUMAN; MALE; MOOD; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RATING SCALE;

ACETIC ACIDS; ADULT; AFFECT; AGED; AMINES; ANTICONVULSANTS; ANXIETY DISORDERS; COMORBIDITY; CYCLOHEXANECARBOXYLIC ACIDS; DEPRESSIVE DISORDER; DRUG THERAPY, COMBINATION; EPILEPSIES, PARTIAL; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; MIDDLE AGED; PERSONALITY INVENTORY; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; TREATMENT OUTCOME;

EID: 0032812841     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1999.tb00830.x     Document Type: Article

References (29)

1. Robertson MM. Affect and mood in epilepsy: an overview with a focus on depression. Acta Neurol Scand Suppl 1992;86(suppl 140): 127-32.
2. Robertson MM, Channon S, Baker J. Depressive symptomatology in a general hospital sample of outpatients with temporal lobe epilepsy: a controlled study. Epilepsia 1994;4:771-7.
3. Blumer D, Montouris G, Hermann B. Psychiatric morbidity in seizure patients on a neurodiagnostic monitoring unit. J Neuropsychiatry Clin Neurosci 1995;7:445-56.
4. Fralin C, Kramer LD, Berman NG, Locke GE. Interictal depression in urban minority epileptics. Epilepsia 1987;28:598.
5. Jacoby A, Baker GA, Steen N, Potts P, Chadwick DW. The clinical course of epilepsy and its psychosocial correlates: findings from a U.K. community study. Epilepsia 1996;37:148-61.
6. Post RM, Ketter TA, Denicoff K, et al. The place of anticonvulsant therapy in bipolar illness. Psychopharmacology 1996;128:115-29.
7. Cullen M, Mitchell P, Brodaty H, et al. Carbamazepine for treatment-resistant melancholia. J Clin Psychiatry 1991;52:472-6.
8. Bowden CL, Brugger AM, Swann AC, et al. Efficacy of divalproex versus lithium and placebo in the treatment of mania. JAMA 1994; 271:918-24.
9. Rock DM, Kelly KM, Macdonald RL. Gabapentin actions on ligand-and voltage-gated responses in cultured rodent neurons. Epilepsy Res 1993;16:89-98.
10. Vollmer K-O, Von Hodenberg A, Kolle EU. Pharmacokinetics and metabolism of gabapentin in rat, dog, and man. Arzneimittelforschung 1986;36:830-9.
11. Saletu B, Grunberger J, Linzmayer L. Evaluation of encephalotropic and psychotropic properties of gabapentin in man by pharmaco-EEG and psychometry. Int J Clin Pharmacol Ther Toxicol 1986;24:362-73.
12. The US Gabapentin Study Group No. 5. Gabapentin as add-on therapy in refractory partial epilepsy: a double-blind, placebocontrolled, parallel-group study. Neurology 1993;43:2292-8.
13. Handforth A, Treiman DM. Efficacy and tolerance of long-term, high-dose gabapentin: additional observations. Epilepsia 1994;35: 1032-7.
14. Dimond KR, Pande AC, Lamoreuax L, Pierce MW. Effect of gabapentin (Neurontin) on mood and well-being in patients with epilepsy. Prog Neuropsychopharmacol Biol Psychiatry 1996;20: 407-17.
15. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;12:371-9.
16. Mason B, Kocsis J, Leon A, et al. Measurement of severity and treatment response in dysthymia. Psychiatr Ann 1993;23:625-31.
17. Beck AT. Depression: clinical, experimental, and theoretical aspects. New York: Hoeber, 1967.
18. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959;32:50-5.
19. Mason B, Kocsis J, Leon A, et al. Assessment of symptoms and change in dysthymic disorder. In: Kocsis JH, Klein DN, eds. Diagnosis and treatment of chronic depression. New York: Guilford Press, 1995:73-88.
20. Mood disorders. In: Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington DC: American Psychiatric Association, 1994:317-91.
21. Keller MB, Klein DN, Hirschfeld RM, et al. Results of the DSMIV mood disorders field trial. Am J Psychiatry 1995;152:843-9.
22. Keller MB, Kocsis JH, Thase ME, et al. and the Sertraline Chronic Depression Group. Maintenance phase efficacy of sertraline for chronic depression: a double-blind, placebo-controlled study. JAMA 1998 (in press).
23. Hellerstein DJ, Yanowitch P, Rosenthal J, et al. A randomized double-blind study of fluoxetine versus placebo in the treatment of dysthymia. Am J Psychiatry 1993;150:1169-75.
24. McElroy Sl, Soutullo CA, Keck PE, Kmetz GF. A pilot trial of adjunctive gabapentin in the treatment of bipolar disorder. Clin Psychiatry 1997;9:99-103.
25. Schaffer CB, Schaffer LC. Gabapentin for the treatment of bipolar disorder [Letter]. Am J Psychiatry 1997;154:291.
26. Bennett J, Goldman WT, Suppes T. Gabapentin in the treatment of bipolar and schizoaffective disorders. J Clin Psychopharmacol 1997;17:141-2.
27. Dodrill CB, Arnett J, Hayes A, Garafalo E, Greeley C, Greiner M, Pierce MW. Gender differences in neuropsychological response to gabapentin. Epilepsia 1997;38(suppl 3):271.
28. Leach JP, Sills GJ, Butler E, Forrest G, Thompson GG, Brodie MJ. Neurochemical actions of gabapentin in mouse brain. Epilepsy Res 1997;27:175-80.
29. Petroff OA, Rothman DL, Behar KL, Lamoureux D, Mattson RH. The effect of gabapentin on brain gamma-aminobutyric acid in patients with epilepsy. Ann Neurol 1996;39:95-9.